Cargando…

Can We Efficiently Target HDAC in Cancer?

Detalles Bibliográficos
Autores principales: Kiesslich, Tobias, Neureiter, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406325/
https://www.ncbi.nlm.nih.gov/pubmed/36011050
http://dx.doi.org/10.3390/cancers14164058
_version_ 1784774093089800192
author Kiesslich, Tobias
Neureiter, Daniel
author_facet Kiesslich, Tobias
Neureiter, Daniel
author_sort Kiesslich, Tobias
collection PubMed
description
format Online
Article
Text
id pubmed-9406325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94063252022-08-26 Can We Efficiently Target HDAC in Cancer? Kiesslich, Tobias Neureiter, Daniel Cancers (Basel) Editorial MDPI 2022-08-22 /pmc/articles/PMC9406325/ /pubmed/36011050 http://dx.doi.org/10.3390/cancers14164058 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Kiesslich, Tobias
Neureiter, Daniel
Can We Efficiently Target HDAC in Cancer?
title Can We Efficiently Target HDAC in Cancer?
title_full Can We Efficiently Target HDAC in Cancer?
title_fullStr Can We Efficiently Target HDAC in Cancer?
title_full_unstemmed Can We Efficiently Target HDAC in Cancer?
title_short Can We Efficiently Target HDAC in Cancer?
title_sort can we efficiently target hdac in cancer?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406325/
https://www.ncbi.nlm.nih.gov/pubmed/36011050
http://dx.doi.org/10.3390/cancers14164058
work_keys_str_mv AT kiesslichtobias canweefficientlytargethdacincancer
AT neureiterdaniel canweefficientlytargethdacincancer